11 days ago
ORKA
AnalystsMichael YeeMichael Yee's Stock Forecasts
AnalystsMichael Yee
Analyst Ranking
Top 15%
#789 out of 5272 analysts
Average Return
+11.22%
Win Rate
47%45 out of 95
Risk vs Reward
Poor
Good
Michael Yee's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Beam Therapeutics IncBEAM | +300.96% | $23.02 | $92.30 | 2020-03-02 - 2021-03-02 | Strong Buy |
Scholar Rock Holding CorpSRRK | +221.62% | $9.02 | $29.01 | 2023-10-25 - 2024-10-24 | Strong Buy |
Rayzebio IncRYZB | +212.45% | $20.00 | $62.49 | 2023-10-10 - 2024-02-23 | Strong Buy |
Denali Therapeutics IncDNLI | +194.23% | $22.69 | $66.76 | 2020-02-24 - 2021-02-24 | Strong Buy |
Kodiak Sciences IncKOD | +157.54% | $10.15 | $26.14 | 2024-12-09 - 2025-12-08 | Strong Buy |
Michael Yee Analyst Color
Get additional color on Michael Yee's coverage of popular stocks
a month ago
ORKA
a month ago
KOD
2 months ago
ANAB
3 months ago
VRTX
3 months ago
GILD
4 months ago
IMCR
4 months ago
IVA
4 months ago
ANAB
4 months ago
BMY
4 months ago
GILD
4 months ago
LLY
a year ago
ALXO
2 years ago
DNLI
2 years ago
NUVB
2 years ago
ALXO
3 years ago
ALGS
3 years ago
MRNA
3 years ago
BIIB
4 years ago
BIIB
Michael Yee's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Oruka Therapeutics IncORKA | 4 | Strong Buy | $100.00 | +54.82% | Maintains | 11 days ago |
Biogen IncBIIB | 7 | Strong Buy | $225.00 | +16.31% | Upgrades | 17 days ago |
Anaptysbio IncANAB | 3 | Strong Buy | $60.00 | -13.46% | Maintains | 18 days ago |
First Tracks Biotherapeutics IncTRAX | 1 | Strong Buy | $45.00 | +130.30% | Initiates Coverage On | 18 days ago |
Amgen IncAMGN | 8 | Strong Buy | $400.00 | +20.59% | Maintains | a month ago |
Merck & Co IncMRK | 1 | Strong Buy | $145.00 | +30.18% | Maintains | a month ago |
Pfizer IncPFE | 2 | Hold | $27.00 | +5.14% | Maintains | a month ago |
Kodiak Sciences IncKOD | 5 | Strong Buy | $80.00 | +95.07% | Maintains | a month ago |
Schrodinger IncSDGR | 3 | Hold | $13.00 | -0.99% | Maintains | 2 months ago |
Nuvation Bio IncNUVB | 5 | Hold | $7.00 | +46.14% | Maintains | 2 months ago |
Arcellx IncACLX | 2 | Hold | $115.00 | -0.06% | Downgrades | 3 months ago |
Damora Therapeutics IncDMRA | 1 | Strong Buy | $45.00 | +86.26% | Initiates Coverage On | 3 months ago |
Abbvie IncABBV | 2 | Hold | $230.00 | +14.12% | Maintains | 3 months ago |
Vertex Pharmaceuticals IncVRTX | 5 | Strong Buy | $545.00 | +26.80% | Maintains | 3 months ago |
Gilead Sciences IncGILD | 4 | Strong Buy | $155.00 | +18.02% | Maintains | 3 months ago |
Ventyx Biosciences IncVTYX | 3 | Hold | $14.00 | 0.00% | Downgrades | 4 months ago |
Ideaya Biosciences IncIDYA | 1 | Strong Buy | $50.00 | +76.55% | Assumes | 4 months ago |
Denali Therapeutics IncDNLI | 3 | Strong Buy | $25.00 | +27.42% | Assumes | 4 months ago |
Immunocore Holdings PLCIMCR | 2 | Strong Buy | $55.00 | +85.94% | Assumes | 4 months ago |
Inventiva SaIVA | 1 | Strong Buy | $12.00 | +123.46% | Assumes | 4 months ago |
Viridian Therapeutics IncVRDN | 1 | Strong Buy | $50.00 | +201.02% | Initiates Coverage On | 4 months ago |
Scholar Rock Holding CorpSRRK | 3 | Strong Buy | $60.00 | +23.99% | Initiates Coverage On | 4 months ago |
Sab Biotherapeutics IncSABS | 1 | Strong Buy | $7.00 | +70.32% | Initiates Coverage On | 4 months ago |
Olema Pharmaceuticals IncOLMA | 1 | Strong Buy | $45.00 | +202.01% | Initiates Coverage On | 4 months ago |
Mbx Biosciences IncMBX | 2 | Strong Buy | $60.00 | +46.47% | Initiates Coverage On | 4 months ago |
Beam Therapeutics IncBEAM | 3 | Hold | $28.00 | -13.37% | Initiates Coverage On | 4 months ago |
Allogene Therapeutics IncALLO | 1 | Strong Buy | $8.00 | +250.88% | Initiates Coverage On | 4 months ago |
Zai Lab LtdZLAB | 1 | Strong Buy | $35.00 | +88.17% | Initiates Coverage On | 4 months ago |
Aligos Therapeutics IncALGS | 2 | Strong Buy | $20.00 | +210.56% | Initiates Coverage On | 4 months ago |
Bristol Myers Squibb CoBMY | 1 | Strong Buy | $65.00 | +15.74% | Upgrades | 4 months ago |
Eli Lilly & CoLLY | 1 | Strong Buy | $1,250.00 | +31.79% | Assumes | 4 months ago |
Cargo Therapeutics IncCRGX | 4 | Hold | $5.00 | +11.86% | Maintains | 10 months ago |
Blueprint Medicines CorpBPMC | 1 | Strong Buy | $135.00 | N/A | Initiates Coverage On | a year ago |
Alx Oncology Holdings IncALXO | 4 | Strong Buy | $3.00 | N/A | Upgrades | a year ago |
Moderna IncMRNA | 8 | Hold | $55.00 | N/A | Maintains | 2 years ago |
Axon Enterprise IncAXON | 3 | Strong Buy | $385.00 | N/A | Initiates Coverage On | 2 years ago |
Immuneering CorpIMRX | 2 | Hold | $3.00 | N/A | Downgrades | 2 years ago |
LianbioLIANY | 2 | Hold | $4.00 | N/A | Downgrades | 2 years ago |
Cerevel Therapeutics Holdings IncCERE | 1 | Hold | $45.00 | N/A | Downgrades | 2 years ago |
Amarin Corp PLCAMRN | 8 | Hold | $20.00 | N/A | Downgrades | 3 years ago |
Rayzebio IncRYZB | 1 | Strong Buy | $35.00 | N/A | Initiates Coverage On | 3 years ago |
Prometheus Biosciences IncRXDX | 1 | Hold | $200.00 | N/A | Downgrades | 3 years ago |
Invivyd IncIVVD | 1 | Strong Buy | $60.00 | N/A | Initiates Coverage On | 5 years ago |
Kyntra Bio IncKYNB | 2 | Hold | $1,125.00 | N/A | Downgrades | 5 years ago |
Esperion Therapeutics IncESPR | 3 | Hold | $30.00 | N/A | Downgrades | 5 years ago |
Prothena Corp Public Ltd CoPRTA | 3 | Strong Buy | $30.00 | N/A | Upgrades | 5 years ago |
Assembly Biosciences IncASMB | 2 | Hold | $120.00 | N/A | Downgrades | 6 years ago |
Inhibrx IncINBX1 | 1 | Strong Buy | $30.00 | N/A | Initiates Coverage On | 6 years ago |
Urogen Pharma LtdURGN | 2 | Strong Buy | $77.00 | N/A | Assumes | 8 years ago |
Immunomedics IncIMMU | 2 | Strong Buy | $30.00 | N/A | Assumes | 8 years ago |
Odonate Therapeutics IncODTC | 1 | Strong Buy | $40.00 | N/A | Initiates Coverage On | 8 years ago |
Acorda Therapeutics IncACORQ | 2 | Hold | $3,000.00 | N/A | Maintains | 9 years ago |
Spectrum Pharmaceuticals IncSPPI | 1 | Strong Buy | $18.00 | N/A | Maintains | 9 years ago |
Intercept Pharmaceuticals IncICPT | 1 | Strong Buy | $275.00 | N/A | Initiates Coverage On | 9 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.